Nerve Blocks for Hip Osteoarthritis
(PENG Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you must not be taking opioids regularly before joining. If you are on opioids, you may need to stop them to participate.
What data supports the effectiveness of the treatment Fascia Iliaca Nerve Block and Pericapsular Nerve Block for hip osteoarthritis?
Research shows that both Fascia Iliaca and Pericapsular Nerve Blocks are effective in reducing pain and improving comfort in patients with hip fractures and during hip surgeries. These treatments help decrease the need for opioids (strong painkillers) and improve patients' ability to move comfortably, which suggests they could be beneficial for hip osteoarthritis as well.12345
Is the nerve block treatment for hip osteoarthritis safe?
Nerve blocks like the fascia iliaca and pericapsular nerve group blocks have been used in hip surgeries, but they can cause decreased strength in the quadriceps (thigh muscles) and increase the risk of falls. These blocks are generally safe but may not be recommended for routine use due to these side effects.12356
How is the Fascia Iliaca Nerve Block and Pericapsular Nerve Block treatment different from other treatments for hip osteoarthritis?
The Fascia Iliaca Nerve Block and Pericapsular Nerve Block are unique because they target specific nerves around the hip joint to relieve pain, potentially reducing the need for opioids and their side effects. These blocks are guided by ultrasound, which helps in precisely targeting the nerves responsible for hip pain, making them a novel approach compared to traditional pain management methods.12357
What is the purpose of this trial?
In order to continue progressing towards outpatient total hip arthroplasty (THA), methods to adequately manage postoperative pain is of paramount importance. The purpose of this study is to quantify the effectiveness of the pericapsular nerve block in total hip arthroplasty in comparison to the fascia iliaca nerve block.
Research Team
Ronald Delanois, MD
Principal Investigator
LifeBridge Health
Eligibility Criteria
This trial is for adults planning to undergo primary total hip arthroplasty using the anterior approach, with an ASA score of 1-3, and who have not been taking opioids. They must be willing to follow study procedures and provide consent. Excluded are those with general anesthesia during surgery, certain conditions like ankylosing spondylitis or chronic pain, opioid tolerance, or allergies to medications used in the nerve blocks.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative
Scheduled pre-operative visit for preparation and baseline assessments
Operative
Participants undergo total hip arthroplasty with assigned nerve block regimen
Post-operative
Participants receive postoperative care and pain management, including monitoring of opioid consumption
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments at 2-week and 4-6 week intervals
Treatment Details
Interventions
- Fascia Iliaca Nerve Block
- Pericapsular Nerve Block
Find a Clinic Near You
Who Is Running the Clinical Trial?
LifeBridge Health
Lead Sponsor
Rubin Institute for Advanced Orthopedics
Collaborator